Memory CD8 T Cells Generated by Cytomegalovirus Vaccine Vector Expressing NKG2D Ligand Have Effector-Like Phenotype and Distinct Functional Features

Front Immunol. 2021 Jun 3:12:681380. doi: 10.3389/fimmu.2021.681380. eCollection 2021.

Abstract

Viral vectors have emerged as a promising alternative to classical vaccines due to their great potential for induction of a potent cellular and humoral immunity. Cytomegalovirus (CMV) is an attractive vaccine vector due to its large genome with many non-essential immunoregulatory genes that can be easily manipulated to modify the immune response. CMV generates a strong antigen-specific CD8 T cell response with a gradual accumulation of these cells in the process called memory inflation. In our previous work, we have constructed a mouse CMV vector expressing NKG2D ligand RAE-1γ in place of its viral inhibitor m152 (RAE-1γMCMV), which proved to be highly attenuated in vivo. Despite attenuation, RAE-1γMCMV induced a substantially stronger CD8 T cell response to vectored antigen than the control vector and provided superior protection against bacterial and tumor challenge. In the present study, we confirmed the enhanced protective capacity of RAE-1γMCMV as a tumor vaccine vector and determined the phenotypical and functional characteristics of memory CD8 T cells induced by the RAE-1γ expressing MCMV. RNAseq data revealed higher transcription of numerous genes associated with effector-like CD8 T cell phenotype in RAE-1γMCMV immunized mice. CD8 T cells primed with RAE-1γMCMV were enriched in TCF1 negative population, with higher expression of KLRG1 and lower expression of CD127, CD27, and Eomes. These phenotypical differences were associated with distinct functional features as cells primed with RAE-1γMCMV showed inferior cytokine-producing abilities but comparable cytotoxic potential. After adoptive transfer into naive hosts, OT-1 cells induced with both RAE-1γMCMV and the control vector were equally efficient in rejecting established tumors, suggesting the context of latent infection and cell numbers as important determinants of enhanced anti-tumor response following RAE-1γMCMV vaccination. Overall, our results shed new light on the phenotypical and functional distinctness of memory CD8 T cells induced with CMV vector expressing cellular ligand for the NKG2D receptor.

Keywords: CD8 T lymphocytes; Klrg1; TCF1; cytomegalovirus; memory T cells; tumor vaccine; vaccine vector.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CD8-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / metabolism*
  • Cancer Vaccines / immunology
  • Computational Biology / methods
  • Cytomegalovirus / immunology
  • Cytomegalovirus Vaccines / immunology*
  • Cytotoxicity, Immunologic
  • Gene Expression Profiling
  • Herpesviridae Infections / immunology
  • Herpesviridae Infections / prevention & control
  • Immunologic Memory*
  • Immunophenotyping
  • Lymphocyte Activation / immunology
  • Mice
  • Muromegalovirus / immunology
  • NK Cell Lectin-Like Receptor Subfamily K / genetics*
  • NK Cell Lectin-Like Receptor Subfamily K / metabolism
  • Phenotype*
  • Transcriptome

Substances

  • Cancer Vaccines
  • Cytomegalovirus Vaccines
  • KLRK1 protein, human
  • NK Cell Lectin-Like Receptor Subfamily K